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UNCERTAINTIES
Do dressings prevent infection of closed primary
wounds after surgery?
Jane Blazeby [on behalf of on behalf of the Bluebelle Study Group]
Centre for Surgical Research, School of Social and Community Medicine, University of Bristol, and Division of Surgery, Head and Neck, University
Hospitals Bristol NHS Foundation Trust, Bristol, UK
After surgery, the wound must try to heal. A dressing may be
applied, with the expectation of improved healing, management
of exudate, or reduced chance of surgical site infection. Surgical
site infection is of particular importance to health services and
patient outcomes. However, whether dressings are necessary
and influence these issues is uncertain. Here we discuss
uncertainty about wound dressings in closed primary surgical
wounds.
A closed primary surgical wound is formed when the skin edges
of the surgical wound are approximated.Wounds may be closed
with sutures or clips. Epithelisation and connective tissue
deposition seal the join. The wound may then be covered with
a dressing. Many different types are available (box 1).1 Tissue
adhesive “glue” may also be added as a dressing to a closed
wound (fig 1⇓).
Theoretically, dressings might limit surgical site infection by
providing a barrier to exogenous environmental contamination
with bacteria, or they might increase surgical site infection by
incubation of endogenous commensal organisms (that is, bacteria
present from the time of surgery). However, a difficulty in
designing any trial to answer this question is that surgical site
infection is hard to define or diagnose. Surgical site infection
is defined by localised signs (redness, heat, pain, and swelling,
and pus may be visible). Diagnosis can be difficult and
confusion arise because a naturally healing wound can exhibit
some of the signs of infection and because microbiological
confirmation of infection is difficult to obtain consistently.
These challenges mean that existing measures of wound
infection, although widely used, have limited validity and
reliability.2-5 Surgical site infection may be superficial, deep, or
affecting an organ space. While superficial infection may be
self-limiting and require minimal intervention, more serious
surgical site infection requires re-operation and a prolonged
hospital stay with a major cost to the health service.6 7 Infection
risk varies according to surgical procedure (clean,
clean/contaminated, contaminated, or dirty), whether surgery
is planned, and patient factors. After high risk, dirty-infected
procedures (such as unplanned colorectal surgery), infection
risk may reach 25%, whereas the risk after elective clean surgery
is typically less than 5% (for example, 4.4% for coronary artery
bypass surgery and 1% for breast surgery).8 If post-discharge
surveillance is undertaken, increased rates of surgical site
infection are noted for all procedures.
What is the evidence of uncertainty?
A Cochrane systematic review summarising the evidence for
the use of dressings or “no dressing” to prevent surgical site
infection in people with closed primary surgical wounds was
published in 2011 and updated in 2014.9 10 Twenty randomised
controlled trials were included. All were at an unclear or high
risk of bias. Only two compared leaving wounds exposed (“no
dressing”) with applying a dressing. The remainder compared
one type of dressing with another; none reviewed tissue adhesive
as a dressing. There was insufficient evidence to conclude which
type of dressing reduced surgical site infection or whether
dressings were needed at all. Evidence for the role of dressings
to manage exudate or symptoms is lacking because validated
and reliable measures of practical wound management and
patient experience are not available.9 10
To supplement the review, we systematically searched for
randomised controlled trials evaluating application of tissue
adhesive as a dressing on closed primary surgical wounds (box
2). We screened 319 abstracts, reviewed 19 full papers, and
included two trials.11 12 Both were small (<100 patients), single
centre, and limited to specific operations (adult abdominoplasty
and paediatric laparoscopic appendectomy). Both were assessed
as having a high or unclear risk of bias. For common operations,
therefore, there is essentially no evidence about the effectiveness
of tissue adhesive when used as a dressing.
The Cochrane review concluded that, because of the lack of
evidence, current decision making about dressings may need to
be informed (perhaps for pragmatic reasons) by practical issues
such as wound symptom management and costs rather than
surgical site infection.
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What you need to know
• There is insufficient evidence to know whether dressings reduce the risk of surgical site infection in closed primary surgical wounds
• Basic adhesive dressings may be used on closed primary surgical wounds as a pragmatic approach to provide a barrier to the wound
and to absorb exudate
• In specialties where it is common practice to not use dressings, continue with this practice until further evidence emerges
Box 1: Summary of dressings types (from the British National Formulary1)
Basic wound contact dressing—Low adherence, usually cotton pads placed in contact with the wound, and may be absorbent
Advanced wound dressings*:
• Hydrogel—Amorphous, cohesive topical application that can take up the shape of a wound
• Vapour permeable†—Allow the passage of water vapour and oxygen but are impermeable to water and micro-organisms
• Soft polymer—Include soft silicone polymer that may be adherent or non-adherent
• Hydrocolloid—Occlusive hydrocolloid layer on a vapour permeable film
• Foam—Contain hydrophilic polyurethane foam (adhesive or non-adhesive)
• Alginate—Highly absorbent calcium alginate or sodium alginate, can be combined with collagen
• Capillary action—Absorbent core of hydrophilic fibres sandwiched between low-adherent wound-contact layers
• Odour absorbent—Contain activated charcoal to absorb odour from wounds
Antimicrobial dressings—May contain honey, iodine, silver, and other antimicrobials
Complex adjuvant therapies—Topical negative pressure therapy
Tissue adhesive as a dressing—Topical skin adhesive
*Defined according to their primary component. †Adhesive and may have absorbent properties recommended for closed
primary surgical wounds
Box 2: Search strategy for trials of tissue adhesive used as a dressing on a closed primary wound
We undertook electronic searches in March 2015 in the Cochrane Wounds Group Specialized Register, Cochrane Central Register of
Controlled Trials (CENTRAL), Ovid Medline and Ovid Medline 5, Ovid Embase, and EBSCO CINAHL databases for randomised controlled
trials that compared the immediate postoperative application of wound dressings with tissue adhesive as a dressing to closed primary surgical
wounds. We included studies of adults or children. The primary intervention was application of tissue adhesive as a dressing: we excluded
trials where tissue adhesive was applied for the purpose of closing the wound.
What are the practical issues and costs of
wound dressings versus no dressing?
Dressings may provide practical wound management and
symptom control. Dressings absorb exudates and provide a
barrier to being directly knocked or caught on something. They
may reduce patient anxiety by covering the incision. Leaving a
wound exposed without a dressing, however, may be beneficial
by providing easy visualisation of the wound to aid prompt
assessment of an impending problem and allay fears of what
might be underneath the dressing. Not covering a closed wound
after surgery may be especially important in children because
it avoids the need for painful removal of dressings. It is possible
that intentionally leaving a wound without a dressing may be
coupled with greater care in skin closure at the end of surgery.
Greater care with closure may reduce wound exudates, which
in turn could negate the need for a dressing and improve healing.
Other issues to consider in choice of dressing is their cost. These
vary greatly, from inexpensive basic wound contact dressings
(a few pence each) to expensive advanced dressings (such as
antimicrobial dressings) which may cost between £10 and £20
each.1 Topical negative pressure therapy dressings are rarely
used on closed primary surgical wounds (costing about £100
per week), although interest in them for high risk wounds (such
as unplanned colorectal surgery) is increasing.
Is ongoing research likely to provide relevant
evidence?
Searches conducted in September 2015 in the WHO
International Clinical Trials Registry have identified only
ongoing trials comparing advanced dressings (with one or more
claimed therapeutic property) with basic wound contact
products. We did not find any trial comparing dressings with
no dressing. A feasibility study which includes a pilot
randomised controlled trial is currently being undertaken which
will establish whether a definitive trial of different dressing
types and no dressing in patients undergoing planned or
unplanned abdominal general and caesarean section surgery is
feasible and a worthwhile investment for the NHS.13 Mixed
methods are being used to explore current practice and views
of dressings and to improve outcome measures.
What dressings, if any, should we use in
light of this uncertainty?
Because there is so little evidence to guide the choice of dressing
strategy for closed primary surgical wounds, we recommend a
common sense approach until better evidence is available.
Without evidence of the superiority of more expensive dressings,
and with anecdotal reports of the convenience of dressings for
patients and health care staff, the use of basic adhesive (with
minimal absorbency) dressings at a cost of a few pence per
dressing on a closed primary surgical wounds is pragmatic. An
exception to this recommendation would be settings in which
it is standard practice not to use dressings, and paediatric surgery
may constitute such an exception, if the removal of dressings
causes undue distress to children.
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Recommendations for future research
A randomised controlled trial to evaluate the effectiveness and cost effectiveness of different dressings or no dressing to reduce surgical
site infection in patients undergoing elective or unplanned non-implant based surgery. Outcomes of interest include
• The feasibility of establishing a valid and reliable patient reported outcome measure to assess surgical site infection after hospital
discharge
• The feasibility of developing an accurate and easy to use tool to assess symptoms and practical wound management issues in the
early postoperative setting
• Cost effectiveness of a major trial of dressing use and strategy for the NHS
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Figure
Fig 1 Images of a closed primary surgical wound (a) without a dressing, (b) with tissue adhesive added “as a dressing,” (c)
with an adherent and transparent dressing, and (d) with an adherent and absorbent dressing
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